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Abstract: Promoting physical activity is a first-line choice of treatment for patients with type 2 
diabetes (T2D). However, there is a need for more effective tools and technologies to facilitate 
structured lifestyle interventions and to ensure a better compliance, sustainability, and health 
benefits of exercise training in patients with T2D. The InterWalk initiative and its innova-
tive application (app) for smartphones described in this study were developed by the Danish 
Centre for Strategic Research in T2D aiming at implementing, testing, and validating interval 
walking in patients with T2D in Denmark. The interval walking training approach consists of 
repetitive 3-minute cycles of slow and fast walking with simultaneous intensity guiding, based 
on the exercise capacity of the user. The individual intensity during slow and fast walking is 
determined by a short initial self-conducted and audio-guided fitness test, which combined 
with automated audio instructions strives to motivate the individual to adjust the intensity to 
the predetermined individualized walking intensities. The InterWalk app data are collected 
prospectively from all users and will be linked to the unique Danish nationwide databases and 
administrative registries, allowing extensive epidemiological studies of exercise in patients with 
T2D, such as the level of adherence to InterWalk training and long-term effectiveness surveys 
of important health outcomes, including cardiovascular morbidity and mortality. Currently, 
the InterWalk app has been downloaded by .30,000 persons, and the achieved epidemiologi-
cal data quality is encouraging. Of the 9,466 persons providing personal information, 80% of 
the men and 62% women were overweight or obese (body mass index $25). The InterWalk 
project represents a contemporary technology-driven public health approach to monitor real-
life exercise adherence and to propagate improved health through exercise intervention in T2D 
and in the general population.
Keywords: exercise, telemedicine, cell phones
Background
It is well documented that increasing physical activity levels is an effective first-line 
treatment for patients with type 2 diabetes (T2D).1,2 There is convincing evidence to 
support important clinical benefits of supervised aerobic training in patients with T2D 
on, for example, hemoglobin A1c level, lipid profile, quality of life, physical fitness, and 
other parameters.3 However, a recent meta-analysis concluded that while performance 
of supervised exercise was effective in improving glycemic control in T2D patients, 
advice about physical activity alone was not effective on this particular outcome.4 
As the number of people with T2D worldwide is estimated to reach 439–552 million 
by 2030,5,6 fully supervised long-term training programs for all T2D patients will be 
very costly and thus unrealistic. Instead, there is a need for improved physical activity 
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rehabilitation programs with high adherence that may be 
implemented in large cohorts of patients with T2D with little 
or no supervision.
More than 60% of the Danish households and 55% of 
all American adults currently have a smartphone.7,8 Using 
a smartphone as a vehicle to promote physical activity thus 
renders a unique, feasible, and cost-effective opportunity to 
improve rehabilitation in a larger proportion of the popula-
tion with T2D. Accordingly, we developed a smartphone 
application (app) – InterWalk – to promote a sustainable 
increase in the physical activity level in the Danish popula-
tion with T2D.
aims
This article describes the rationale behind and the develop-
ment and design of the InterWalk smartphone app. Further-
more, this article outlines the planned scientific evaluation 
of the nationwide InterWalk implementation.
Methods and design
Reflections and perspectives related to 
interval walking training in patients with 
T2D
An increasing body of evidence suggests that the intensity 
and modality (eg, interval vs continuous training) of physi-
cal activity play an important role for improving clinically 
relevant outcomes in T2D, independent of the total physical 
activity volume.9 One of these new modalities is interval 
walking training (IWT), developed and evaluated in seve-
ral studies of healthy, elderly Japanese people.10–13 IWT 
consists of repetitive cycles of 3 minutes of fast and slow 
walking during free living guided by an accelerometer-based 
portable training device (JD Mate; Kissei Comtec Co., Ltd, 
Matsumoto, Japan).14 These initial studies showed benefi-
cial effects on body composition, blood pressure, physical 
fitness, and strength measurements, combined with a high 
level of adherence (.95%) over a period of 4 months in a 
healthy elderly population (N.700), despite a minimum of 
supervision.12,13
With its individualized physical activity intensity, IWT 
was potentially a feasible intervention for T2D patients. Thus, 
Karstoft et al15 examined the feasibility of implementing 
the IWT modality among patients with T2D in a free-living 
environment and compared it to energy expenditure-matched 
continuous walking training and to a control group. In this 
4-month randomized controlled trial, IWT, but not continu-
ous walking training, improved key metabolic parameters 
relevant for patients with T2D.15 Indeed, IWT resulted in 
a 16% increase in physical fitness level, a 3 kg decrease 
in body fat mass, and a decrease in hyperglycemic levels 
without accompanying hypoglycemic episodes. Moreover, 
this was achieved with a compliance rate of ∼85% and very 
low loss to follow-up.
At the end of the clinical trial, we administered a brief 
questionnaire to acquire information about the participants’ 
motivation to continue the training intervention (Figure 1) 
and what possible factors could motivate them to continue 
(Figure 2). At the 1-year follow-up, we asked both the 
continuous walking group and the interval walking group 
about their motivation to continue the training interven-
tion (Figure 3). The encouraging feedback along with the 
clinically significant results inspired us to move forward 
with regard to implementing the interval walking modality 
in rehabilitation programs for patients with T2D.
The development process of the InterWalk app (Visual-
logic, Nyborg, Denmark) is described in Figure 4. To develop a 
setting and to test the vehicle to deliver IWT, we implemented 
the JD Mate in a municipality-based rehabilitation program. 
During this iteration, we identified several barriers to suc-
ceed with large-scale implementation. The barriers included 
difficult data transfer, thus complicating the deliverance of 
feedback to the user (upload is performed using a computer), 
usability (the device language was Japanese), and reliability 
(∼15% of all devices malfunctioned during the iteration). 
However, the pattern of motivational factors was similar to 
what we had observed in the clinical trial (Figure 2).
Based on this, we developed a smartphone app (Inter-
Walk) with features similar to those of the JD Mate using a 
participatory design. Briefly, the participatory design pro-
poses inclusion of all key stakeholders including the users 
during the design of the intervention.16,17 First, we identified 
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Figure 1 Degree of motivation to continue the training intervention among 
participants at the end of a 4-month clinical trial assessing the efficacy of interval 
walking training.
Notes: Participants were randomized to continuous walking training (cWT) or 
interval walking training (iWT). The participants were asked to rate the degree of 
motivation.
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key stakeholders in the rehabilitation of persons with T2D 
in Denmark18 and arranged a series of workshops. The key 
stakeholders were identified as persons with T2D, rehabilita-
tion therapists from the Danish municipalities, personnel at 
hospital-based outpatient clinics, and the Danish Diabetes 
Association. Initially, the JD Mate user feedback was used 
to develop two different app design mockups. The designs 
were tested in a municipality rehabilitation setting, in a peer-
to-peer setting in collaboration with the Danish Diabetes 
Association, and in a hospital outpatient clinic (n=17). Feed-
back from the focus group interviews was incorporated in 
the design of the app (Cosmographic A/S, Denmark). Prior 
to release in AppStore, pilot testing of the beta version was 
performed in the municipality T2D rehabilitation program 
(n=18), and feedback was used to further adjust app func-
tionalities, including increased user feedback and graphical 
presentation of the exercise history (Figure 4).
The app Version 1.0 was released in AppStore in 
November 2013, and a subsequent test of unsupported use 
was performed and evaluated by observations and focus group 
interviews (n=25) in collaboration with the Danish Diabetes 
Association. The participants found the InterWalk app to be 
manageable and meaningful in their everyday life. However, 
there was a need for an extension of the help function, an 
increased focus on retaining the quality of the exercise, and an 
automated data upload function from iPods. Finally, based on 
the user feedback from the therapists in three Danish munici-
palities, the current version was updated with an increased vol-
ume of the audio and voice feedback. This version of InterWalk 
was released to AppStore in  December 2015. This trial has been 
registered with the NCT under number NCT01234155.
nationwide data linking of the interWalk 
training data
The Danish civil registration number (Central Personal 
Registry [CPR] number) is a unique personal identifier, pro-
vided to all Danish residents at birth or migration into Denmark. 
The CPR number is used to register each citizen’s primary and 
secondary health care contacts, redeemed prescription medica-
tions, education and income statistics, and other information 
from the Danish health and administrative databases.19 Provid-
ing the CPR number is mandatory in order to use the InterWalk 
app. The CPR number is automatically hashed (see Data logg ing 
and storage) and uploaded to a central server, together with 
collected training data after each test and training session. 
Using the CPR number in InterWalk allows for subsequent 
secure data linkage in later research projects, with access to 
baseline and follow-up health data for each individual.20 The 
CPR number is thus pivotal in order to study the implementa-
tion of the InterWalk app and the long-term health effects of 
InterWalk usage.
interWalk design and content description
The InterWalk app is developed for use on smartphones with 
the Apple iPhone Operating System or Android Operating 
System (Version 2.3 or higher for LG and HTC) operating 
systems and consists of the following subcomponents: an 
IWT program using audio guidance to help the user through 
the session, a fitness test used for setting the intensity during 
IWT, an IWT history for the user to keep track of progress, 
logging of accelerometer, and Global Positioning System 
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Figure 2 level of agreement with statements regarding what would motivate the 
participants to continue to perform walking training at the end of a 4-month clinical 
trial assessing the efficacy of interval walking training.
Notes: Participants were randomized to continuous walking training (cWT) or 
interval walking training (iWT).
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Figure 3 Degree of motivation to continue the training intervention among 
participants at 1-year follow-up following the 4-month clinical trial assessing the 
efficacy of interval walking training.
Notes: Participants were randomized to continuous walking training (cWT) or 
interval walking training (iWT). The participants were asked to rate the degree of 
motivation.
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(GPS) data obtained during the IWT sessions, and an indi-
vidualized fitness test. The subcomponents are described 
in detail later. Upon the first use of the app, a user profile 
needs to be completed (CPR number, sex, body weight in 
kilograms, and height in centimeters). Before engaging in 
IWT, the app recommends completion of a fitness test. This 
will set the  individual user exercise intensity during IWT. 
The layout of the front page of the InterWalk app is depicted 
in Figure 5A.
interval walking training
IWT consists of repeated cycles of 3 minutes of slow and fast 
walking. The individualized walking intensity for slow and 
fast walking during IWT is calculated from accelerometer 
Action
• Mockup of possible app designs
• Implementation of JD mate
  features in an smartphone app
• First version of the InterWalk app
  design (beta version)
• InterWalk webpage (Danish)
• Reduction in battery use increased
  user feedback (ie, geo-
  information, distance, voice
  feedback, and steps)
• Presentation of exercise history
• Increased focus on exercise
  quality (ie, smileys [figure X])
• Extended help function
• Automated iPod data upload
• InterWalk app user manual
• Release of first Android version
Test of unsupported use of the InterWalk app in
“motivation groups” (patient organization)
• Duration of intervention: 3 weeks
• N=25, T2D, 3 men/22 women, 40–79 years
Test functionality of the InterWalk app in a
municipality based rehabilitation (beta version).
• Duration of intervention: 17 weeks
• N=25, T2D, 6 men/8 women, 36–82 years
Test mockups of the InterWalk app by focus
group interviews (municipality, patient
organization, outpatient clinic)
• Duration of intervention: 3-hours single session
• N=18, T2D, 10 men/8 women, age 49–77 years
Testing the usability of the IWT in a municipality-
based rehabilitation setting using the JD mate
• Duration of intervention: 17 months
• N=57, T2D, 27 men/30 women, age 24–77 years
• Increased volume of audio
  feedback during test and training
Release v. 2.1
Release v. 2.0
Release v. 1.0
Pre-release beta-version
T2D user feedback from implementation in the
municipality based rehabilitation
continuous user feedback to therapists
Iteration
Clinical study*
1
2
3
4
5
Content
Figure 4 Development process of the InterWalk app after a 4-month clinical trial (*) assessing the efficacy of interval walking training.
Abbreviations: iWT, interval walking training; T2D, type 2 diabetes.
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data  collected during the fitness test. It is possible to do IWT 
without a prior fitness test; however, in that case, walking 
intensity audio guidance will not be available. As a large 
proportion of the target group is assumed to be untrained, we 
have proposed an in-app progression in the “help” function 
specifying the training duration per session and training fre-
quency for beginners (10–20 minutes, three times per week), 
intermediate users (20–30 minutes, three times per week), 
and advanced users (.30 minutes, more than three times per 
week). The duration and frequency should be increased in 
steps of 10 minutes until the users are able to complete five 
sessions per week of 60 minutes per session. This progression 
in training volume was determined based on user interviews 
and expert consensus.
The fitness test
The test is a standardized 7-minute walking test protocol. 
The user is encouraged on the start-up screen of the app 
to perform the test before engaging in IWT for the first 
time. The protocol consists of four consecutive walking 
intervals: slow (2 minutes), intermediate (2 minutes), fast 
(2 minutes), and very fast walking (1 minute). Prior to the 
first and immediately after the last walking intensity, users 
are instructed to stand still for 30 seconds and 60 seconds, 
respectively, in order for the app to detect a valid GPS sig-
nal (protocol shown in Figure 5B). The walking intensity 
is self-selected, that is, what “slow walking,” “fast walk-
ing,” and so on imply is defined by the user. The onset of 
the test and each alternation in walking intensity are audio 
guided, thus automatically instructing the user to start and 
subsequently change the walking intensity according to the 
above-described walking intensities. The training start page 
is depicted in Figure 5C. Upon use, it is recommended on the 
app screen that the smartphone is placed near the  waistline 
or in the side pockets of the pants while  performing the 
test and IWT.
Walking intensity during iWT
The IWT intensity is based on the accelerometer recording 
during the fitness test. The smartphone on-board accelerometer 
is recording acceleration with a 100 Hz sampling frequency. 
Acceleration from x, y, and z axes is used to calculate the vector 
magnitude as the square root of the summed squared accelera-
tion from the x, y, and z axes. Subsequently, the magnitude is 
averaged across 10 seconds during IWT (10-second epochs) 
and 30 seconds during the individual fitness test (30-second 
epochs). The slow walking cutoff intensity during IWT is 
calculated as the mean acceleration between slow and inter-
mediate walking intensity during the last 30 seconds of these 
intervals in the fitness test. The fast walking cutoff intensity is 
calculated as the mean acceleration of the intermediate and fast 
walking intensity during the last 30 seconds of this interval in 
the fitness test. If the user exceeds these cutoffs during IWT, 
the audio guidance encourages the user to slow down (for slow 
walking) or speed up (for fast walking).
iWT history and postsession feedback
After terminating each IWT session or fitness test, the app 
displays data from the session performed (Figure 5D). His-
torical training data are also available (Figure 5E). These 
include information about walking distance in kilometers 
(calculated from GPS), number of steps, duration, and the 
quality of performance of the IWT sessions. The quality 
of an IWT session is determined as the fraction of training 
time (percentage), which the user has spent below (for slow 
walking) or above (for fast walking) the intensity cutoffs. This 
performance quality information is delivered to the user by 
four different smiley icons (Figure 6).
A B C D E
Figure 5 layout of the interWalk app (translated from Danish).
Notes: (A) The front page and the interWalk app logo, (B) the protocol for the fitness test, (C) the start page including the user progression (smileys) across the current 
and previous weeks, (D) the immediate feedback after an interWalk session, and (E) the historical interWalk user data.
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Data logging and storage
The epoch level accelerometer data and GPS coordinates 
during interval walking and the fitness test are immediately 
transferred to a central server using either WIFI or the mobile 
data network (100 bytes/s) after terminating each session. 
Data are also stored on the device for up to 8 days in case 
no network is available upon termination of a session. When 
the device connects to a network and the app is engaged, the 
recent locally stored data are then automatically transferred 
to the server. Accelerometer and GPS data are transferred 
along with the hashed CPR number and self-reported user 
data. The hash algorithm, called SHA-256, adds extra values 
to the CPR number and translates it into a string. The SHA-
256 is a one-way algorithm, that is, dehashing is only possible 
by comparing two encryption keys generated from identical 
CPR numbers. Other information in the InterWalk app is not 
hashed but cannot be connected to the CPR number. Stored 
data are described in Table 1.
Dissemination of the interWalk app – 
current status
The InterWalk app was released into the general population 
via the iTunes App Store in November 2013 (updated March 
2014) and on Google Play in October 2014. The app is free 
of charge. It is actively promoted by the Danish Centre for 
Strategic Research in Type 2 Diabetes (DD2, www.dd2.nu), 
the Danish Diabetes Association and partner municipalities 
through their websites, and at the InterWalk webpage www.
interwalk.dk (in Danish).
Currently (92 weeks postrelease), 31,829 persons have 
downloaded the InterWalk app from the iTunes App Store 
(N=27,647) or Google Play (N=4,182). Of these, 9,466 per-
sons (30%) entered their CPR number and were included 
in the cohort. Table 2 describes the baseline characteristics 
upon cohort entry (first use of the app). Fewer men (29%) 
downloaded and entered their CPR number than women 
(71%). Generally, the male participants were older than the 
women (median age 60 years vs 54 years). Few participants 
were of normal weight, and men had a higher prevalence 
of overweight (41% vs 32% with body mass index [BMI] 
25–29.9) and obesity (39% vs 33% with BMI $30) than 
did women. Women more often downloaded the app on an 
iPhone mobile operating system compared to men, whereas 
men more often downloaded the app on an Android operat-
ing system (Table 2).
research plan
The health impact of a nationwide implementation of health 
care mobile solutions such as the InterWalk app on the popu-
lation with T2D is still uncertain. Researchers in Denmark 
will be able to retrieve a large number of outcome measures 
and confounding factors by taking advantage of linkage with 
the already existing health databases. This renders a unique 
opportunity to evaluate health impacts of releasing and 
implementing the InterWalk app into the Danish population 
with T2D.21
Planned initial data analyses
Data collected during InterWalk use will potentially enable 
researchers to answer important research questions on physi-
cal exercise promotion. Initially, nationwide data linkage and 
analysis may answer questions such as 1) What are the indi-
vidual predictors, for example, age, sex, sociodemographic 
characteristics, comorbidities, of IWT uptake, that is, of 
using the InterWalk app and of its sustained usage? 2) Does 
the use of the InterWalk app affect the subsequent risk of 
incident hospitalizations with cardiovascular events, other 
>75% of the IWT has been performed at the correct intensity
<15% of the IWT has been performed at the correct intensity
40–75% of the IWT has been performed at the correct intensity
15–40% of the IWT has been performed at the correct intensity
Figure 6 interpretation of the smiley feedback system.
Abbreviation: iWT, interval walking training.
Table 1 iWT and user data transferred to the server from the 
smartphone
Variables Data source
acceleration (m/s2) (vector magnitude) accelerometer
geographical location gPs
intensity cutoffs (m/s2) accelerometer
Distance covered (km) gPs
Frequency of use Upload
Training duration (min) accelerometer
Quality of iWT (% correct physical activity intensity) accelerometer
steps accelerometer
Body height (cm) self-report
Body weight (kg) self-report
sex self-report
cPr self-report
name self-report
Abbreviations: iWT, interval walking training; gPs, global Positioning system; 
cPr, central Personal registry.
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incident disease outcomes, and total mortality? 3) Does the 
use of the InterWalk app affect total health care expenditure 
and consumption?
Use of external data sources
The InterWalk data will be linked with data available in 
the DD2 project database. The DD2 project cohort (cur-
rent N.6,900) prospectively enrolls newly diagnosed 
patients with T2D from all Danish general practitioners 
and hospital clinics; it includes biobank data from blood 
and urine samples along with baseline examination data on, 
for example, self-reported physical activity, family history 
of T2D, body weight at age of 20 years, resting heart rate, 
and waist and hip circumference. Data on a range of other 
variables (eg, smoking, blood pressure, lipids, hemoglobin 
A1c, comorbidities, medications) are ascertained through 
data linkage with other databases.22 Furthermore, in a 
subgroup of the DD2 cohort, patients’ quality of life and 
mental state are prospectively evaluated using the SF12 and 
WHO-5 questionnaires.23 The DD2 data set is linked with the 
National Danish Prescription Registry, the National Danish 
Patient Register, and the Civil Registration System providing 
continuous up-to-date information on all incident hospital 
contacts and mortality.24,25
All statistical analyses are performed at the DD2 data 
management center, Department of Clinical Epidemiology at 
Aarhus University Hospital, Denmark. The InterWalk project 
has been approved by the Danish Data Protection Agency 
(approval number 2008-58-0035). The Ethical Scientific 
Committee of Southern Denmark considers the InterWalk 
setup a health promoting initiative; thus, no written consent 
from the participants or further approval from the committee 
is needed for this study (S-20122000-77).
Discussion
The InterWalk app has now been freely available to the broad 
Danish population for ∼2 years. This study provides a descrip-
tion of the InterWalk project and app and of the baseline 
characteristics of the persons who have entered the cohort 
with their CPR number during the first ∼2 years.
The prevalence of InterWalk app users being either over-
weight (BMI $25) or obese (BMI $30) was higher compared 
to the Danish population of similar age (ages 45–74 years) 
with a prevalence odds ratio (95% confidence intervals) of 
2.1 (1.9–2.3) for men and 1.8 (1.7–1.9) for women.26 For 
obesity (BMI $30) only, the prevalence was also increased 
for both male and female app users, with a prevalence odds 
ratio (95% confidence intervals) of 2.8 (2.6–3.0) for men 
and 2.2 (2.1–2.3) for women as compared to representative 
Danish reference data (ages 45–74 years).26 The increased 
prevalence of overweight and obesity in the InterWalk cohort 
compared to the Danish reference population suggests that the 
InterWalk app is in fact of interest for the at-risk (overweight 
and obese) individuals in the population.
There is a societal interest in developing effective and sus-
tainable (feasible and outcome-efficient) methods to promote 
physical activity for the general population, in particular for 
people with inactivity-associated diseases such as T2D. Using 
mobile technology in T2D self-management is of growing 
interest due to the feasibility of long-distance consultation 
and self-monitoring of the intervention. Besides being a 
T2D self-management tool for the individual patient, the 
InterWalk app offers municipalities and clinicians a readily 
available tool to promote individualized and unsupervised 
structured physical activity in a free-living setting. To suc-
ceed with implementation of mobile solutions such as the 
InterWalk app, knowledge is needed about factors motivating 
Table 2 Sample characteristics at first registration
All Men Women
n 9,466 (100%) 2,784 (29%) 6,682 (71%)
age (years) 55.6 (46.4–63.6) 59.7 (50.3–66.8)* 54.0 (44.5–61.9)
Body weight (kg) 80.0 (69.0–95.0) 92.0 (82.0–105.0)* 75.0 (66.0–88.0)
Body height (cm) 170.0 (165.0–178.0) 180.0 (175.0–184.0)* 168.0 (163.0–172.0)
BMi 27.4 (24.1–31.6) 28.4 (25.6–32.2)* 26.7 (23.6–31.2)
Weight status (BMI [kg/m2]*)
normal weight (BMi ,25), n (%) 3,028 (31.1) 568 (20.4) 2,475 (37.1)
Overweight (BMi $25 and ,30), n (%) 3,310 (34.9) 1,144 (41.1) 2,160 (32.3)
Obese (BMi $30), n (%) 3,127 (33.0) 1,072 (38.5) 2,047 (30.6)
Mobile operating system*
iPhone operating system, n (%)a 6,972 (73.5) 1,913 (73.5) 5,049 (80.2)
android, n (%)a 1,799 (19.0) 692 (26.5) 1,101 (19.8)
Notes: Data are medians (interquartile range) or actual numbers (relative frequency). asubsample of 8,771 users (only registered in Version 1.1). *P,0.001 for sex differences 
(Wilcoxon’s signed rank test or Fisher’s exact test).
Abbreviation: BMi, body mass index.
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adherence. Knowledge is also needed on how additional 
transition into other settings of physical activity (eg, fitness 
centers or other mobile solutions) can be facilitated. Although 
primarily developed for patients with T2D, the InterWalk app 
could be used to promote physical activity in other patient 
groups, including “hard-to-reach” groups such as patients 
with cancer. However, more research on adaption to these 
groups is needed.
The development of the InterWalk app was done in 
collaboration between key stakeholders (patients, patient 
associations, and clinicians) in order to increase the accept-
ability, user-friendliness, and graphical design. Inclusion 
of these stakeholders is pivotal in increasing adherence 
to e-health solutions.27 We find it likely that the InterWalk 
app could be implemented to a degree that would impact 
overall health in populations with T2D; yet, this needs 
to be evaluated in future observational and randomized 
controlled trials.
As more knowledge is gained about the usage of the 
InterWalk app, additional information on motivational predic-
tors of the app usage will also be collected, shedding light on 
the potential impact on quality of life in T2D. Furthermore, 
since almost ∼30,000 Danes have already downloaded the 
InterWalk app, there is a large potential to reach even more 
people over time.
As we expect the InterWalk app to be used in the general 
population, not only in patients with T2D, analyses on the 
potential effectiveness on health outcomes in the nondiseased 
general population will also be possible in the future.
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